Cardio-oncology A-Z: Radiation Induced Heart Disease With Dr Joshua Mitchell

Watch on Radcliffe Cardiology: https://www.radcliffecardiology.com/video-index/cardio-oncology-z-radiation-induced-heart-disease-dr-joshua-mitchell?utm_source=youtube&utm_medium=organic_social&utm_term=&utm_campaign=DELV-7058&utm_content=az-z_mitchell

In this video we asked, Dr Joshua Mitchell, Assistant Professor of Medicine at Washington University School of Medicine and the Director of our Cardio-Oncology Centre Of Excellence, to summarise the topic of radiation induced heart disease. Dr Mitchell's clinical interests include cardiotoxicity from cancer therapy and cancer survivorship.

Discussion Points:
1. Types of Radiation Induced Heart Disease
2. RIHD Risk Factors
3. How common is RIHD?
4. When to Monitor or Screen Patients?
5. Methods to minimise radiation to the heart
6. How can RIHD best managed?

About the A-Z series:
In recent years, cardio-oncology (C-O) emerged as a subspeciality focusing on the cardiac management of cancer patients. In our new Cardio-oncology A to Z series we are aiming to provide you short summaries of C-O concepts curated by Dr Arjun Ghosh and delivered by practicing experts of this field.

Recorded remotely from Columbus, 2022.
This content is intended for healthcare professionals only.

Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.